WO2007100913A2 - Gènes exprimés de façon différentielle dans les troubles bipolaires et/ou dans la schizophrénie - Google Patents
Gènes exprimés de façon différentielle dans les troubles bipolaires et/ou dans la schizophrénie Download PDFInfo
- Publication number
- WO2007100913A2 WO2007100913A2 PCT/US2007/005404 US2007005404W WO2007100913A2 WO 2007100913 A2 WO2007100913 A2 WO 2007100913A2 US 2007005404 W US2007005404 W US 2007005404W WO 2007100913 A2 WO2007100913 A2 WO 2007100913A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- genes
- screening
- expression
- group
- human
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
- C40B40/08—Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0817080A GB2449819A (en) | 2006-02-28 | 2007-02-28 | Genes differentially expressed in bipolar disorder and/or schizophrenia |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77794506P | 2006-02-28 | 2006-02-28 | |
US60/777,945 | 2006-02-28 | ||
US84024806P | 2006-08-25 | 2006-08-25 | |
US60/840,248 | 2006-08-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007100913A2 true WO2007100913A2 (fr) | 2007-09-07 |
WO2007100913A3 WO2007100913A3 (fr) | 2008-12-04 |
Family
ID=38459686
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/005404 WO2007100913A2 (fr) | 2006-02-28 | 2007-02-28 | Gènes exprimés de façon différentielle dans les troubles bipolaires et/ou dans la schizophrénie |
Country Status (3)
Country | Link |
---|---|
US (2) | US20080075789A1 (fr) |
GB (1) | GB2449819A (fr) |
WO (1) | WO2007100913A2 (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009140665A2 (fr) * | 2008-05-16 | 2009-11-19 | Vanda Pharmaceuticals, Inc. | Procédé de traitement |
WO2009082743A3 (fr) * | 2007-12-24 | 2009-11-19 | Suregene Llc | Marqueurs génétiques de la schizophrénie et des troubles bipolaires |
CN104120172A (zh) * | 2013-04-28 | 2014-10-29 | 上海交通大学 | 精神分裂症的基因标志物及其使用方法和应用 |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9183349B2 (en) | 2005-12-16 | 2015-11-10 | Nextbio | Sequence-centric scientific information management |
EP1964037A4 (fr) | 2005-12-16 | 2012-04-25 | Nextbio | Systeme et procede pour la gestion de connaissances d'informations scientifiques |
US20100256001A1 (en) * | 2007-04-03 | 2010-10-07 | The Scripps Research Institute | Blood biomarkers for mood disorders |
US20130166320A1 (en) * | 2011-09-15 | 2013-06-27 | Nextbio | Patient-centric information management |
US10143684B1 (en) * | 2014-09-23 | 2018-12-04 | University Of Massachusetts | Aberrant sonic hedgehog signaling in neuropsychiatric disorders |
GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
WO2020212948A1 (fr) | 2019-04-17 | 2020-10-22 | Compass Pathfinder Limited | Procédés pour traiter les troubles neurocognitifs, la douleur chronique, et pour réduire l'inflammation |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5006462A (en) * | 1988-03-16 | 1991-04-09 | Abbott Laboratories | Method for the detection of schizophrenia |
US7625697B2 (en) * | 1994-06-17 | 2009-12-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for constructing subarrays and subarrays made thereby |
NO972006D0 (no) * | 1997-04-30 | 1997-04-30 | Forskningsparken I Aas As | Ny metode for diagnose av sykdommer |
WO1999055915A2 (fr) * | 1998-04-29 | 1999-11-04 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services | IDENTIFICATION DE POLYMORPHISMES DANS LA REGION PCTG4 DE Xq13 |
US7067627B2 (en) * | 1999-03-30 | 2006-06-27 | Serono Genetics Institute S.A. | Schizophrenia associated genes, proteins and biallelic markers |
CA2359816C (fr) * | 1999-01-06 | 2010-08-03 | Genenews Inc. | Technique de detection de transcrits geniques dans le sang et leur utilisation |
US20040241727A1 (en) * | 1999-01-06 | 2004-12-02 | Chondrogene Limited | Method for the detection of schizophrenia related gene transcripts in blood |
US20070031841A1 (en) * | 2001-02-28 | 2007-02-08 | Choong-Chin Liew | Method for the detection of gene transcripts in blood and uses thereof |
US20050123938A1 (en) * | 1999-01-06 | 2005-06-09 | Chondrogene Limited | Method for the detection of osteoarthritis related gene transcripts in blood |
US20070105121A1 (en) * | 1999-01-06 | 2007-05-10 | Chondrogene Limited | Method for the detection of schizophrenia related gene transcripts in blood |
US6395482B1 (en) * | 1999-01-13 | 2002-05-28 | The Rockfeller University | Method of determining susceptibility to schizophrenia |
US20040110938A1 (en) * | 2000-02-24 | 2004-06-10 | Parekh Rajesh Bhikhu | Proteins, genes and their use for diagnosis and treatment of schizophrenia |
US20020142303A1 (en) * | 2000-02-24 | 2002-10-03 | Parekh Rajesh Bhikhu | Proteins, genes and their use for diagnosis and treatment of Schizophrenia |
CA2414403A1 (fr) * | 2000-07-06 | 2002-01-17 | The Regents Of The University Of California | Procede destine au diagnostic et au traitement de troubles mentaux |
CN1468306A (zh) * | 2000-08-07 | 2004-01-14 | ��ɪ�ع�˾ | 与精神分裂症相关的基因及蛋白质 |
US6468479B1 (en) * | 2000-08-11 | 2002-10-22 | Sabre Oxidation Technologies, Inc. | Chlorine dioxide generator |
IL137865A0 (en) * | 2000-08-15 | 2001-10-31 | Yeda Res & Dev | Method for the diagnosis and follow-up of schizophrenia |
WO2002016653A2 (fr) * | 2000-08-24 | 2002-02-28 | University Of Pittsburgh | Procedes et systemes conçus pour faciliter le diagnostic et le traitement de la schizophrenie |
AU2001287448A1 (en) * | 2000-09-01 | 2002-03-13 | The Governing Council Of The University Of Toronto | Proteins related to schizophrenia and uses thereof |
UA79927C2 (en) * | 2000-12-05 | 2007-08-10 | Serono Genetics Inst Sa | Polynucleotide, coding a polypeptide of potential-depending portal ionic human channel (canion), polypeptyde, antibody, method for identification of candidate modulator of canion-polypeptyde, method for treatment of bipolar disorder or schizophrenia and use of an antibody for production of drugs for treatment of schizophrenia or bipolar disorder |
US20030027153A1 (en) * | 2001-01-09 | 2003-02-06 | Meyer Joanne M. | Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia |
US20030092019A1 (en) * | 2001-01-09 | 2003-05-15 | Millennium Pharmaceuticals, Inc. | Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia |
US20030054345A1 (en) * | 2001-01-24 | 2003-03-20 | Millennium Pharmaceuticals, Inc. | Compositions and methods for the diagnosis and treatment of neuropsychiatric disorders, including schizophrenia |
US20030008301A1 (en) * | 2001-02-02 | 2003-01-09 | Pamela Sklar | Association between schizophrenia and a two-marker haplotype near PILB gene |
US20070072233A1 (en) * | 2001-05-01 | 2007-03-29 | Levitt Pat R | Methods and systems for facilitating the diagnosis and treatment of schizophrenia |
US7341844B2 (en) * | 2002-01-16 | 2008-03-11 | Regents Of The University Of Minnesota | Methods for diagnosing autism |
IL163645A0 (en) * | 2002-02-21 | 2005-12-18 | Idgene Pharmaceuticals Ltd | Association of snps in the comt locus and neighboring loci with schizophrenia, bipolar disorder, breast cancer and colorectal cancer |
EP1487998B1 (fr) * | 2002-03-20 | 2007-06-06 | Novartis AG | Methode pour diagnostiquer et traiter la schizophrenie |
US6764824B2 (en) * | 2002-03-21 | 2004-07-20 | Council Of Scientific And Industrial Research | Primers for screening schizophrenia and a method thereof |
US7745180B2 (en) * | 2002-04-24 | 2010-06-29 | Hitachi Chemical Co., Ltd. | Device and method for high-throughput quantification of mRNA from whole blood |
GB0211212D0 (en) * | 2002-05-16 | 2002-06-26 | Seeman Philip | Schizophrenia: homozygous CAA insert in an untranslated region of Nogo (reticuion 4 ) |
AU2003250033A1 (en) * | 2002-07-11 | 2004-02-02 | Novartis Ag | Genes associated with schizophrenia, adhd and bipolar disorders |
US20050026152A1 (en) * | 2002-07-23 | 2005-02-03 | Norbert Muller | Methods of screening for schizophrenia |
MXPA05005071A (es) * | 2002-11-12 | 2005-07-22 | Becton Dickinson Co | Diagnostico de la sepsis o sirs usando perfiles de biomarcadores. |
US20070015152A1 (en) * | 2002-12-12 | 2007-01-18 | Novartis Ag | Methods for diagnosing and treating schizophrenia |
US20080070237A1 (en) * | 2003-08-11 | 2008-03-20 | Brunskill Eric W | Npas3 Mutant Mice and Uses for Screening and Testing Therapies for Schizophrenia and Related Neurological Disorders |
US20050208519A1 (en) * | 2004-03-12 | 2005-09-22 | Genenews Inc. | Biomarkers for diagnosing schizophrenia and bipolar disorder |
HU227246B1 (en) * | 2004-04-30 | 2010-12-28 | Szegedi Biolog Koezpont | Use of genes as molecular markers in diagnosis of schizophrenia and diagnostic kit |
US20070087376A1 (en) * | 2004-08-30 | 2007-04-19 | Potashkin Judith A | Splice variants of pre-mRNA transcripts as biomarkers in idiopathic neurodegenerative diseases |
WO2006026602A2 (fr) * | 2004-08-30 | 2006-03-09 | Rosalind Franklin University Of Medicine And Science | Transcripts a epissage alterne pre-arnm dans des maladies neurodegeneratives |
US7736852B2 (en) * | 2004-12-11 | 2010-06-15 | The Trustees Of The University Of Pennsylvania | Methods and compositions for treating and diagnosing mood disorders, schizophrenia, and neuro-psychiatric disorders |
CA2578071A1 (fr) * | 2004-12-24 | 2006-06-29 | Ares Trading S.A. | Compositions et methodes de traitement des troubles mentaux |
EP1851342A2 (fr) * | 2005-02-15 | 2007-11-07 | The Regents of The University of California San Diego | Detection de biomarqueurs correspondant a des troubles neuropsychiatriques |
JP2008538007A (ja) * | 2005-04-15 | 2008-10-02 | ベクトン,ディッキンソン アンド カンパニー | 敗血症の診断 |
WO2008028257A1 (fr) * | 2006-09-08 | 2008-03-13 | Garvan Institute Of Medical Research | diagnostics et thérapeutiques d'une maladie neurologique |
US20080181882A1 (en) * | 2006-11-15 | 2008-07-31 | The University Of Pennsylvania | Neurgulin 1 (NRG1) - ErbB4 signaling as a target for the treatment of schizophrenia |
US20090006001A1 (en) * | 2007-06-29 | 2009-01-01 | Indiana University Research And Technology Corporation | Empirical quantitative approaches for psychiatric disorders phenotypes |
-
2007
- 2007-02-28 GB GB0817080A patent/GB2449819A/en not_active Withdrawn
- 2007-02-28 WO PCT/US2007/005404 patent/WO2007100913A2/fr active Application Filing
- 2007-02-28 US US11/712,827 patent/US20080075789A1/en not_active Abandoned
-
2010
- 2010-05-13 US US12/779,854 patent/US20100305103A1/en not_active Abandoned
Non-Patent Citations (3)
Title |
---|
BEZCHLIBYNK Y. ET AL.: 'Gene Expression Differences in Bipolar Disorder Revealed by cDNA Array Analysis of Post-mortem Frontal Cortex' J. NEUROCHEMISTRY vol. 79, 2001, pages 826 - 834, XP002319164 * |
LIPSKA B.K.: 'Critical Factors in Gene Expression in Postmortem Human Brain: Focus on Studies in Schizophrenia' BIOL. PSYCHIATRY vol. 60, 2006, pages 650 - 658, XP005662820 * |
SHAO L. ET AL.: 'Shared Gene Expression Alteractions in Schizophrenia and Biopolar Disorder' BIOL. PSYCHIATRY vol. 64, 2008, pages 89 - 97, XP022762359 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009082743A3 (fr) * | 2007-12-24 | 2009-11-19 | Suregene Llc | Marqueurs génétiques de la schizophrénie et des troubles bipolaires |
US8460868B2 (en) | 2007-12-24 | 2013-06-11 | Suregene Llc | Genetic markers for schizophrenia and bipolar disorder |
WO2009140665A2 (fr) * | 2008-05-16 | 2009-11-19 | Vanda Pharmaceuticals, Inc. | Procédé de traitement |
WO2009140665A3 (fr) * | 2008-05-16 | 2010-01-28 | Vanda Pharmaceuticals, Inc. | Procédé de traitement |
JP2011520920A (ja) * | 2008-05-16 | 2011-07-21 | ヴァンダ ファーマシューティカルズ インコーポレイテッド | 治療方法 |
CN104120172A (zh) * | 2013-04-28 | 2014-10-29 | 上海交通大学 | 精神分裂症的基因标志物及其使用方法和应用 |
CN104120172B (zh) * | 2013-04-28 | 2018-11-09 | 上海交通大学 | 精神分裂症的基因标志物及其使用方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
US20080075789A1 (en) | 2008-03-27 |
US20100305103A1 (en) | 2010-12-02 |
WO2007100913A3 (fr) | 2008-12-04 |
GB0817080D0 (en) | 2008-10-29 |
GB2449819A (en) | 2008-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007100913A2 (fr) | Gènes exprimés de façon différentielle dans les troubles bipolaires et/ou dans la schizophrénie | |
CN105143467B (zh) | 用于预测间质性肺炎的风险的方法 | |
US11591655B2 (en) | Diagnostic transcriptomic biomarkers in inflammatory cardiomyopathies | |
US20090208939A1 (en) | Identification of Molecular Diagnostic Markers for Endometriosis in Blood Lymphocytes | |
JP2013505001A (ja) | 臨床サンプル中のインターフェロン応答(iris) | |
KR101657051B1 (ko) | 만성폐쇄성폐질환 진단용 마커 조성물 | |
WO2006132983A2 (fr) | Expression diferentielle de molecules associees au risque de maladie vasculaire | |
US20140171371A1 (en) | Compositions And Methods For The Diagnosis of Schizophrenia | |
WO2007137366A1 (fr) | Indicateurs de diagnostic et de pronostic du cancer | |
JP2024507981A (ja) | うつ病の診断及び抗うつ剤治療に対する応答の予測のための環状rna | |
US20130217656A1 (en) | Methods and compositions for diagnosing and treating lupus | |
KR20220039065A (ko) | 대장암에 대한 항암제 감수성 예측을 위한 신규 바이오마커 | |
WO2011041725A2 (fr) | Biomarqueurs de réponse à un traitement de la schizophrénie | |
WO2008127524A2 (fr) | Biomarqueurs présentant une réponse anti-dépressive très rapide et un mécanisme de réponse anti-dépressive très rapide | |
KR102646011B1 (ko) | Brd3의 단일염기다형성을 이용한 비소세포폐암의 예후 진단방법 | |
KR102576154B1 (ko) | 습관성 유산 예측용 바이오마커 | |
KR102259708B1 (ko) | 대장암에 대한 항암제 감수성 예측을 위한 신규 바이오마커 | |
CA2768475A1 (fr) | Procedes et kits utilises dans l'evaluation du risque de cancer | |
KR101873903B1 (ko) | 고혈압의 예후 또는 위험도를 평가하는 방법 및 키트 | |
WO2022103947A2 (fr) | Détection de polymorphisme du promoteur de lactotransferrine et de mif pour la détection et le traitement du cancer | |
KR20230138820A (ko) | Mpz 유전자의 돌연변이를 포함하는, 신규한 샤르코-마리-투스병 진단용 바이오마커 및 이의 용도 | |
KR20230136786A (ko) | 췌장암의 진단용 조성물 | |
KR20150081632A (ko) | 약물에 의한 간 손상 유형을 조기에 진단하기 위한 정보를 제공하는 방법 | |
WO2003016476A2 (fr) | Profils d'expression genique de maladies glomerulaires | |
KR20210125456A (ko) | 전이 여부에 따른 방광암의 예후 진단용 조성물 및 키트 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 0817080 Country of ref document: GB Kind code of ref document: A Free format text: PCT FILING DATE = 20070228 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 817080 Country of ref document: GB Ref document number: 0817080.5 Country of ref document: GB |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07752125 Country of ref document: EP Kind code of ref document: A2 |